CLINICAL_TRIALS
research
· 2019-10-10
Clinical Trial Update: The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS. [Phase 3]
Summary
Phase 3 clinical trial exploring the role of gut microbiota dysbiosis in the pathogenesis of Polycystic Ovary Syndrome (PCOS).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Polycystic Ovary Syndrome | Phase 3 | Status: UNKNOWN